Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rena Eudy"'
Autor:
Rena Eudy‐Byrne, Nicole Zane, Susan C. Adeniyi‐Jones, Marc R. Gastonguay, Ana Ruiz‐Garcia, Gagan Kaushal, Walter K. Kraft
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2171-2183 (2021)
Abstract Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of tre
Externí odkaz:
https://doaj.org/article/36acd5d7a6f74a369d135df943dae29b
Publikováno v:
British Journal of Clinical Pharmacology.
Autor:
Gagan Kushal, Nicole R. Zane, Ana Ruiz-Garcia, Marc R. Gastonguay, Rena Eudy-Byrne, Susan C. Adeniyi-Jones, Walter K. Kraft
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2171-2183 (2021)
Clinical and Translational Science
Clinical and Translational Science
Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of treatment an
Population pharmacokinetic (PK) and pharmacokinetic- pharmacodynamic (PK-PD) models were used to quantify the exposure-response (E-R) relationship between nalbuphine exposure and 2 widely used rating scales for itch: the Numerical Rating Scale for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d65659c821ab60205d63bd855b9d4d69
https://doi.org/10.22541/au.166177100.03899983/v1
https://doi.org/10.22541/au.166177100.03899983/v1
Autor:
Marvin J. Meyers, Paula M. Loria, Li She, Xiangyang Chen, David W. Piotrowski, Neil Raheja, Agustin Casimiro-Garcia, Kun Song, Catherine M. Ambler, Liuqing Wei, Graciela B. Arhancet, Derek Vrieze, Sandra M. Jennings, Carine M. Boustany-Kari, Catherine Angela Hulford, Rena Eudy, Cuiman Cai, Mary Ellen Banker, David Hepworth, Tereece Banks, Matthew F. Sammons, Donna N. Petersen
Publikováno v:
Journal of medicinal chemistry. 57(10)
A novel series of nonsteroidal mineralocorticoid receptor (MR) antagonists identified as part of our strategy to follow up on the clinical candidate PF-03882845 (2) is reported. Optimization departed from the previously described pyrazoline 3a and fo
Autor:
David W. Piotrowski, Amanda King-Ahmad, Paula M. Loria, Carine M. Boustany-Kari, Rena Eudy, Meera Tugnait, Vaishali Sahasrabudhe, Mary Ellen Banker, Kristen Near, Kevin Sweeney
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 9, Iss 1, p 180 (2011)
Journal of Translational Medicine, Vol 9, Iss 1, p 180 (2011)
Background Accumulating evidence supports the role of the mineralocorticoid receptor (MR) in the pathogenesis of diabetic nephropathy. These findings have generated renewed interest in novel MR antagonists with improved selectivity against other nucl